Risk stratification tools in prostate cancer, where do we stand?
Transl Androl Urol
.
2021 Jan;10(1):12-18.
doi: 10.21037/tau-20-1211.
Authors
Andries Clinckaert
1
,
Gaëtan Devos
1
,
Eduard Roussel
1
,
Steven Joniau
1
Affiliation
1
Department of Urology, University Hospitals Leuven, Leuven, Belgium.
PMID:
33532290
PMCID:
PMC7844509
DOI:
10.21037/tau-20-1211
No abstract available
Publication types
Editorial
Comment